IPO Boutique Research, Color & More Information for Subscribers
This content is restricted to IPO Boutique Subscribers Username or E-mail: Become a Subscriber Disclaimer IPO Boutique aggregates information on public companies and private companies, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual[…]
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Neos Therapeutics Symbol: NEOS Price: Last trade $5.80 Description: Re-offer $5.00 Trade Date: 2/3 Shares: 5 million Underwriter(s)Cowen & Co., BMO[…]
The summer swell of IPOs hitting the market continued in July as 19 deals priced this past month. As many pundits like to make headlines of the number of new issues coming to market in 2015, there actually continues to be fewer deals debuting as compared to this time last year. In July 2014 a[…]
This past week three IPOs debuted, seven updated terms and two new deals filed. Of the three deals that debuted, Blue Buffalo Pet Products (Nasdaq: BUFF) opened with the most strength. After upsizing and pricing above range ($20.00), ‘BUFF’ opened with a 35% premium with a $27.00 first trade. The deal traded as high as[…]
Become a subscriber of IPOBoutique to obtain ratings and get real-time color of new IPOs building up to each of the companies debuts. There are one-time, monthly and annual plans available. Wednesday, July 22 Blue Buffalo Pet Products (Nasdaq: BUFF) Thursday, July 23 ETRE REIT (Nasdaq: ESSF) Neos Therapeutics (Nasdaq: NEOS) Live Oak Bancshares (Nasdaq:[…]